Micro-bioreactors are used to create the right environment for microorganisms to grow or to derive biochemically active substances from them. Factors such as an increase in biopharmaceutical companies' adoption of micro bioreactors for research activities and an increase in the use of biologics are expected to drive the global market for micro bioreactors in the coming years.

The micro bioreactor serves as a set of scale-down bioprocess needs based on mammalian cells. In terms of complexity, micro bioreactors include everything from micro-tier-based systems to complex computerised parallel bioreactors for efficient up/down scalability of standard pilot and large-scale bioprocesses. Although many micro bioreactors are currently designed for batch and fed-batch processing, with many firms focusing on the development of continuously operating chemostat-mode micro bioreactors. Increasing applications and adoption of this technique in the pharmaceutical, food and other industries for the manufacturing of several product lines is expected to boost the market for micro bioreactors over the forecast timeframe. In addition, during the projected timeline, the market for micro bioreactors is expected to drive the development of this promising concept by different life sciences companies.

Due to the wide presence of pharmaceutical companies and the significant increase in the use of micro bioreactors for the production of novel ingredients and drugs for specific/uncured diseases, Europe is the second most significant region, followed by North America in the global micro-bioreactor market. Due to the high presence of research & development laboratories, the UK, Germany and many other European countries hold significant market share in Europe's micro bioreactor market.

Adroit Market Research study on the global market for micro-bioreactors offers a holistic view of the industry from 2020 to 2028 as forecast period, including factors such as market drivers, limitations, opportunities, threats and regulatory overview. The market has been analyzed from 2018 to 2028, with a base year estimate of 2019 and a projection from 2020 to 2028. The report covers the current status and potential characteristics of the market at both the global and the country level. Moreover, the report also assesses market competition with Porter's analysis of five strengths and places leading players on the basis of their product range, regional presence, strategic initiatives and overall sales. Prominent players in the global market have been analyzed in depth.

Key vendors in the market include Mani Dharma Biotech Pvt.Ltd, PreSens Precision Sensing, RUAG Space Nyon, Chemtrix, CerCell, Applikon Biotechnology, Merck Millipore, Eppendorf, Stedim, Pall Corporation, and many more.

Key Segments of the Global Micro-bioreactors Market

Product Type Overview, 2018-2028 (USD Million)

• 48 Parallel Bioreactors
• 24 Parallel Bioreactors
• Others

End UserOverview, 2018-2028 (USD Million)

• Pharmaceutical
• Biotech
• Academic Institutions
• Others

Application Overview, 2018-2028 (USD Million)

• Pharmaceutical
• Sewage Treatment
• Biochemical Engineering
• Food Industry
• Others

Regional Overview, 2018-2028 (USD Million)

• North America
  • U.S.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Rest of Asia-Pacific
• Middle East and Africa
  • UAE
  • South Africa
  • Rest of Middle East and Africa
• South America
  • Brazil
  • Rest of South America